System violated the SDWA by failing to comply with the Stage 2 DBPR MCL requirements for TTHMs and HAA5s for 1st - 3rd quarters 2013 and 3rd - 4th quarters 2014. Cost of on-going release is $10,000, which includes the cost of preparing CAP and treatment change.